Concerns regarding ISPD Recommendations for Peritonitis in Relation to Imipenem/Cilastatin

Abstract

Get full access to this article

View all access options for this article.

References

van Gelder

M.K.

, van Eck van der Sluijs

, van Maarseveen

E.M.

, Klein Klouwenberg

P.M.C.

, Abrahams

A.C.

Response letter to the “ISPD peritonitis recommendations: 2016 update on prevention and treatment”.

Perit Dial Int 2017; 37(5): 584.

P.K.

, Szeto

C.C.

, Piraino

, de Arteaga

, Fan

, Figueiredo

A.E.

ISPD peritonitis recommendations: 2016 update on prevention and treatment.

Perit Dial Int 2016; 36: 481–508.

Brown

E.A.

, Bargman

J.M.

, Li

P.K.

Managing older patients on peritoneal dialysis.

Perit Dial Int 2015; 35: 609–11.

Szeto

C.C.

Peritoneal dialysis-related infection in the older population.

Perit Dial Int 2015; 35: 659–62.

Deslandes

, Grégoire

, Bouquié

, Le Marec

, Allard

, Dailly

Stability and compatibility of antibiotics in peritoneal dialysis solutions applied to automated peritoneal dialysis in the pediatric population.

Perit Dial Int 2016; 36: 676–9.

Anwar

, Merchant

, Were

, Tooth

, Uttley

, Gokal

A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD.

Perit Dial Int 1995; 15: 167–71.

Concerns regarding ISPD Recommendations for Peritonitis in Relation to Imipenem/Cilastatin—In Reply

Abstract

Get full access to this article

References